Avalglucosidase alfa

Generic name: Avalglucosidase Alfa
Brand names: Nexviazyme
Dosage form: intravenous injection (ngpt 100 mg)
Drug class: Lysosomal enzymes

Usage of Avalglucosidase alfa

Avalglucosidase alfa helps replace an enzyme that is missing in people with a genetic disorder called late-onset Pompe disease, (also called GAA deficiency) in children at least 1 year old.

Avalglucosidase alfa may also be used for purposes not listed in this medication guide.

Avalglucosidase alfa side effects

Get emergency medical help if you have signs of an allergic reaction: hives, itching; difficult breathing; swelling of your face, lips, tongue, or throat.

Some reactions may occur during the injection, or within a few hours afterward. Tell your medical caregiver or get emergency medical help right away if you have:

wheezing, cough, chest discomfort, trouble breathing;

pale skin, blue lips or fingernails;

swelling in your tongue;

trouble swallowing;

dizzines, nausea;

rash; or

flushing (sudden warmth, redness, or tingly feeling).

Tell your caregivers or get emergency medical help right away if you have any signs of a severe allergic reaction, such as itching, rash, redness or tingling, chest discomfort, wheezing, trouble breathing or swallowing, swelling in your face, pale skin, and blue lips or fingernails.

Common side effects of avalglucosidase alfa may include:

headache, dizziness, feeling tired;

nausea, vomiting, diarrhea;

itching, rash, redness;

muscle or joint pain;

trouble breathing; or

numbness, tingling, burning pain.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Avalglucosidase alfa

Tell your doctor if you have ever had:

heart disease; or

lung disease or breathing problems.

Tell your doctor if you are pregnant or plan to become pregnant. Having untreated Pompe disease during pregnancy may increase your risk of worsened breathing problems and joint or muscle problems. The benefit of treating Pompe disease may outweigh any risks.

Ask a doctor if it is safe to breastfeed while using avalglucosidase alfa.

Your name may be listed on the Pompe Registry. This is to track the progress of your disease and the outcome of your treatment with avalglucosidase alfa.

Relate drugs

How to use Avalglucosidase alfa

Usual Adult Dose for Pompe disease:

Less than 30 kg: 40 mg/kg IV every 2 weeksAt least 30 kg: 20 mg/kg every 2 weeksComments:-The patient's actual body weight should be used to calculate the dose.Use: For the treatment of patients with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency)

Usual Pediatric Dose for Pompe disease:

1 year or older:-Less than 30 kg: 40 mg/kg IV every 2 weeks-At least 30 kg: 20 mg/kg every 2 weeksComments:-The patient's actual body weight should be used to calculate the dose.Use: For the treatment of patients with late-onset Pompe disease (lysosomal GAA deficiency)

Warnings

Tell your caregivers or get emergency medical help right away if you have any signs of a severe allergic reaction, such as itching, rash, redness or tingling, chest discomfort, wheezing, trouble breathing or swallowing, swelling in your face, pale skin, and blue lips or fingernails.

What other drugs will affect Avalglucosidase alfa

Other drugs may affect avalglucosidase, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.